Literature DB >> 9990726

Biotransformation of monoterpenes, bile acids, and other isoprenoids in anaerobic ecosystems.

P B Hylemon1, J Harder.   

Abstract

Isoprenoic compounds play a major part in the global carbon cycle. Biosynthesis and mineralization by aerobic bacteria have been intensively studied. This review describes our knowledge on the anaerobic metabolism of isoprenoids, mainly by denitrifying and fermentative bacteria. Nitrate-reducing beta-Proteobacteria were isolated on monoterpenes as sole carbon source and electron donor. Thauera spp. were obtained on the oxygen-containing monoterpenes linalool, menthol, and eucalyptol. Several strains of Alcaligenes defragrans were isolated on unsaturated monoterpenes as growth substrates. A novel denitrifying beta-Proteobacterium, strain 72Chol, mineralizes cholesterol completely to carbon dioxide. Physiological studies showed the presence of several oxidative pathways in these microorganisms. Investigations by organic geochemists indicate possible contributions of anaerobes to early diagenetic processes. One example, the formation of p-cymene from monoterpenes, could indeed be detected in methanogenic enrichment cultures. In man, cholic acid (CA) and chenodeoxycholic acid (CDCA), are synthesized in the liver from cholesterol. During their enterohepatic circulation, bile acids are biotransformed by the intestinal microflora into a variety of metabolites. Known bacterial biotranformations of conjugated bile acids include: deconjugation, oxidation of hydroxy groups at C-3, C-7 and C-12 with formation of oxo bile acids and reduction of these oxo groups to either alpha- or beta-configuration. Quantitatively, the most important bacterial biotransformation is the 7 alpha-dehydroxylation of CA and CDCA yielding deoxycholic acid and lithocholic acid, respectively. The 7 alpha-dehydroxylation of CA occurs via a novel six-step biochemical pathway. The genes encoding several enzymes that either transport bile acids or catalyze various reactions in the 7 alpha-dehydroxylation pathway of Eubacterium sp. strain VPI 12708 have been cloned, expressed in Escherichia coli, purified, and characterized.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9990726     DOI: 10.1111/j.1574-6976.1998.tb00382.x

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  26 in total

1.  Galacto-oligosaccharides and Colorectal Cancer: Feeding our Intestinal Probiome.

Authors:  Jose M Bruno-Barcena; M Andrea Azcarate-Peril
Journal:  J Funct Foods       Date:  2015-01       Impact factor: 4.451

2.  Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.

Authors:  Guoxiang Xie; Xiaoning Wang; Fengjie Huang; Aihua Zhao; Wenlian Chen; Jingyu Yan; Yunjing Zhang; Sha Lei; Kun Ge; Xiaojiao Zheng; Jiajian Liu; Mingming Su; Ping Liu; Wei Jia
Journal:  Int J Cancer       Date:  2016-06-17       Impact factor: 7.396

3.  Biodegradation of free phytol by bacterial communities isolated from marine sediments under aerobic and denitrifying conditions.

Authors:  J F Rontani; P C Bonin; J K Volkman
Journal:  Appl Environ Microbiol       Date:  1999-12       Impact factor: 4.792

4.  Anaerobic degradation of ethylbenzene by a new type of marine sulfate-reducing bacterium.

Authors:  Olaf Kniemeyer; Thomas Fischer; Heinz Wilkes; Frank Oliver Glöckner; Friedrich Widdel
Journal:  Appl Environ Microbiol       Date:  2003-02       Impact factor: 4.792

Review 5.  Recent advances in petroleum microbiology.

Authors:  Jonathan D Van Hamme; Ajay Singh; Owen P Ward
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

Review 6.  The gut microbiome, kidney disease, and targeted interventions.

Authors:  Ali Ramezani; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

Review 7.  Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.

Authors:  Ali Ramezani; Ziad A Massy; Björn Meijers; Pieter Evenepoel; Raymond Vanholder; Dominic S Raj
Journal:  Am J Kidney Dis       Date:  2015-11-15       Impact factor: 8.860

8.  Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease.

Authors:  Carsten Gnewuch; Gerhard Liebisch; Thomas Langmann; Benjamin Dieplinger; Thomas Mueller; Meinhard Haltmayer; Hans Dieplinger; Alexandra Zahn; Wolfgang Stremmel; Gerhard Rogler; Gerd Schmitz
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

Review 9.  Gut microbiome in chronic kidney disease: challenges and opportunities.

Authors:  Anitha Nallu; Shailendra Sharma; Ali Ramezani; Jagadeesan Muralidharan; Dominic Raj
Journal:  Transl Res       Date:  2016-04-30       Impact factor: 7.012

10.  Study of anoxic and oxic cholesterol metabolism by Sterolibacterium denitrificans.

Authors:  Yin-Ru Chiang; Wael Ismail; Dimitri Heintz; Christine Schaeffer; Alain Van Dorsselaer; Georg Fuchs
Journal:  J Bacteriol       Date:  2007-11-26       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.